AAM
UTHR icon

Archipel Asset Management’s United Therapeutics UTHR Stock Holding History

Archipel Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-3,852
Closed -$341K – 149
2014
Q2 		$341K Buy
+3,852
New +$370K 0.09% 56

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Archipel Asset Management's UTHR Position: Q3 2014 in Review

Archipel Asset Management sold out of United Therapeutics (UTHR) in Q3 2014, closing a stake of 3,852 shares — an estimated $341K sold.

Archipel Asset Management first reported a position in UTHR in Q2 2014 and held it in 1 quarter. The position peaked at $341K in Q2 2014. 319 funds tracked by Wall St. Rank hold UTHR as of Q3 2014.

  • Archipel Asset Management reported no remaining United Therapeutics position as of Q3 2014 after selling out during the quarter.
  • Archipel Asset Management sold 3,852 United Therapeutics shares in Q3 2014, an estimated $341K.
  • Archipel Asset Management first reported a position in United Therapeutics in Q2 2014 and held it in 1 quarter.
  • Archipel Asset Management's United Therapeutics position peaked at $341K in Q2 2014.
  • 319 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2014.

Based on Archipel Asset Management's 13F filing for Q3 2014, filed 15 Oct 2014.